PT94381A - Processo para a preparacao de uma composicao contendo um imunogeno para tratamentos antialergicos - Google Patents

Processo para a preparacao de uma composicao contendo um imunogeno para tratamentos antialergicos

Info

Publication number
PT94381A
PT94381A PT94381A PT9438190A PT94381A PT 94381 A PT94381 A PT 94381A PT 94381 A PT94381 A PT 94381A PT 9438190 A PT9438190 A PT 9438190A PT 94381 A PT94381 A PT 94381A
Authority
PT
Portugal
Prior art keywords
histamine
immunogen
peptide
phe
preparation
Prior art date
Application number
PT94381A
Other languages
English (en)
Other versions
PT94381B (pt
Inventor
Denis Raymond Stanworth
Ian Victor Lewin
Sarita Nayyar
Valerie Jones
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of PT94381A publication Critical patent/PT94381A/pt
Publication of PT94381B publication Critical patent/PT94381B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT94381A 1989-06-15 1990-06-15 Processo para a preparacao de uma composicao contendo um imunogeno para tratamentos antialergicos PT94381B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913737A GB8913737D0 (en) 1989-06-15 1989-06-15 A novel anti-allergy treatment

Publications (2)

Publication Number Publication Date
PT94381A true PT94381A (pt) 1991-02-08
PT94381B PT94381B (pt) 1996-11-29

Family

ID=10658467

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94381A PT94381B (pt) 1989-06-15 1990-06-15 Processo para a preparacao de uma composicao contendo um imunogeno para tratamentos antialergicos

Country Status (18)

Country Link
US (1) US5601821A (pt)
EP (2) EP0477231B1 (pt)
JP (2) JPH04505922A (pt)
KR (1) KR0181313B1 (pt)
AT (1) ATE122401T1 (pt)
CA (1) CA2057860C (pt)
DE (1) DE69019348T2 (pt)
DK (1) DK0477231T3 (pt)
ES (1) ES2073028T3 (pt)
FI (1) FI104723B (pt)
GB (2) GB8913737D0 (pt)
IE (1) IE71677B1 (pt)
NO (1) NO914937L (pt)
NZ (1) NZ234085A (pt)
PH (1) PH30233A (pt)
PT (1) PT94381B (pt)
WO (1) WO1990015878A1 (pt)
ZA (1) ZA904670B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
US5958708A (en) * 1992-09-25 1999-09-28 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
AU5957794A (en) * 1992-12-21 1994-07-19 Uab Research Foundation, The Compositions and method for the inhibition of phagocytes
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
WO1994025060A1 (en) * 1993-04-27 1994-11-10 Ladd Anna E Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
CN1146772A (zh) * 1994-03-28 1997-04-02 美国联合生物医学公司 用于治疗过敏反应的合成肽免疫原
GB9412714D0 (en) * 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
GB9416321D0 (en) * 1994-08-12 1994-10-05 Peptide Therapeutics Ltd Peptides and antibodies and their use in treatment of carcinomas
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
CA2245497C (en) * 1996-03-01 2009-02-24 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
CA2256900A1 (en) * 1996-05-29 1997-12-04 Xiao-Ying Meng Cationic polymer/lipid nucleic acid delivery vehicles
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6573372B2 (en) 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of
US6887472B2 (en) 2000-08-30 2005-05-03 Pfizer Inc. Anti-IgE vaccines
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
JP2003047482A (ja) * 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
RU2191602C1 (ru) * 2001-06-01 2002-10-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций
EP1450856B1 (en) 2001-09-14 2009-11-11 Cytos Biotechnology AG Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
DE60336902D1 (de) 2002-07-19 2011-06-09 Cytos Biotechnology Ag Impfstoffzusammensetzungen enthaltende amyloid beta 1-6 antigenarrays
WO2004016750A2 (en) 2002-08-14 2004-02-26 Macrogenics, Inc. FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
JP2007534743A (ja) 2004-04-26 2007-11-29 イネイト・ファーマ アジュバント組成物およびその使用方法
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
JP5437797B2 (ja) 2006-06-12 2014-03-12 サイトス バイオテクノロジー アーゲー Ｒｎａバクテリオファージのウイルス様粒子にオリゴヌクレオチドをパッケージ化するための方法
AU2007281876B2 (en) 2006-06-26 2013-09-05 Macrogenics, Inc. FcgammaRIIB-specific antibodies and methods of use thereof
SG174161A1 (en) * 2009-02-25 2011-11-28 Tsewen Chang ANTI-CemX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES
CN104603150A (zh) 2012-04-20 2015-05-06 中央研究院 与CH4和CεmX结构域之间的连接处结合的抗mIgE抗体
US11234445B2 (en) * 2016-03-18 2022-02-01 Genclis Molecular origin of allergy
EP3703753A4 (en) 2017-10-31 2021-08-18 Oneness Biotech Co., Ltd. TREATMENT OF ALLERGIC DISEASES MEDIA BY IGE
JP7503857B2 (ja) * 2022-04-11 2024-06-21 緑茵生技股▲ふん▼有限公司 抗アレルギー性ペプチド及びその免疫調節と抗アレルギーに用いられる用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
EP0000252B1 (en) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
EP0344211A4 (en) * 1987-02-20 1990-03-12 Imclone Systems Inc MONOCLONAL ANTIBODIES IN VACCINE COMPOSITIONS.
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤
EP0605410B1 (en) * 1990-05-25 1995-08-16 Peptide Therapeutics Limited Immunodiagnostic assay for rheumatoid arthritis
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH04505922A (ja) 1992-10-15
AU5814890A (en) 1991-01-08
KR0181313B1 (ko) 1999-04-01
FI915891A0 (fi) 1991-12-13
CA2057860C (en) 2000-05-09
WO1990015878A1 (en) 1990-12-27
NZ234085A (en) 1991-09-25
EP0403312A1 (en) 1990-12-19
DE69019348D1 (de) 1995-06-14
IE902154L (en) 1990-12-15
ATE122401T1 (de) 1995-05-15
DK0477231T3 (da) 1995-07-10
GB8913737D0 (en) 1989-08-02
NO914937D0 (no) 1991-12-13
ZA904670B (en) 1992-02-26
KR920702723A (ko) 1992-10-06
CA2057860A1 (en) 1990-12-16
EP0477231B1 (en) 1995-05-10
EP0477231A1 (en) 1992-04-01
IE902154A1 (en) 1991-01-02
GB9013478D0 (en) 1990-08-08
IE71677B1 (en) 1997-02-26
PT94381B (pt) 1996-11-29
AU646808B2 (en) 1994-03-10
JP2000152783A (ja) 2000-06-06
ES2073028T3 (es) 1995-08-01
DE69019348T2 (de) 1995-09-21
NO914937L (no) 1991-12-19
PH30233A (en) 1997-02-05
FI104723B (fi) 2000-03-31
US5601821A (en) 1997-02-11

Similar Documents

Publication Publication Date Title
GB8913737D0 (en) A novel anti-allergy treatment
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
EP0759067A4 (en) TRANSFORMING GROWTH FACTOR ALPHA H1
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
ATE118784T1 (de) Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.
ZA846191B (en) Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp
GR3007031T3 (pt)
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
ATE65407T1 (de) Verfahren zur herbeifuehrung der ovulation.
NO900758L (no) Fremgangsmaate for fremstilling av hybridprotein.
GR3036249T3 (en) Coccidiosis poultry vaccine
EP0299050A4 (en) ISOLATION OF SINGLE-CHAIN PROTEINS WITH FSH-SUPPRESSING ACTIVITY FROM FOLLICULAR LIQUID.
ZA856655B (en) Cross-reactive and protective epitopes of circumsporozoite proteins
WO1997039029A3 (en) An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
HU9500185D0 (en) Vaccines against metazoan parasites
ATE136586T1 (de) Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
ZA896942B (en) Allelic variants of plasmodium falciparum merozoite surface antigen
Xu et al. PA161 ISOLATION OF PORCINE PANCREATIC POLYPEPTIDE AND PORCINE SPASMOLYTIC PEPTIDE
DE69012328D1 (de) Srif-verwandte peptide und deren verwendungen.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960829

PC3A Transfer or assignment

Free format text: 980211 PEPTIDE THERAPEUTICS LIMITED GB

TE3A Change of address (patent)

Owner name: PEPTIDE THERAPEUTICS LIMITED

Effective date: 19990729

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20050228